Enanta Pharmaceuticals | ENTA - 普通股股本



金融业
股票价格
USD 11.47
资产
USD 329.5M
现金及等价物
USD 37.44M
流动资产
USD 198.68M
流动负债
USD 44.73M
债务
USD 1.35M
股息收益率
0
EBIT
USD -23.54M
EBITDA
USD -36.06M
员工
145
EPS每股收益
USD -1.05
股本和储备
USD 126.59M
销售毛利
-22.29M
债务利息支出
USD 1.96M
贷款资金
USD 0
市值
USD 247M
净收入
USD -22.29M
营业费用
USD 126.59M
营业利润
USD -23.54M
普通股股本
USD 212K
税前利润
USD -22.71M
销售收入
USD 16.96M
销售和管理费用
USD -1.05
贸易债权人
USD 1.89M
应收帐款人
USD 40.16M


普通股股本 更改 日
AbbVie USD 1.77B 1.75B 2025-06
Amgen USD 541M 1000K 2026-06
Anika Therapeutics USD 13.89M 532K 2025-12
Arrowhead Research USD 141.14M 564K 2026-06
AstraZeneca USD 1.55B 44K 2026-06
BioCryst Pharmaceuticals USD 255.26M 42.2M 2026-06
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Enanta Pharmaceuticals USD 212K 1000 2023-12
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
Halozyme Therapeutics USD 114.04M 4.48M 2026-06
Heron Therapeutics USD 188.31M 4.99M 2025-12
Immunic USD 120.38M 21.73M 2025-12
Incyte USD 200.98M 1.03M 2026-06
Insmed USD 218.28M 1.76M 2026-06
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
J&J USD 2.41B 1.64M 2026-06
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Merck USD 2.47B 4.93M 2026-03
Neurocrine Biosciences USD 100.55M 50K 2026-06
Novartis USD 1.9B 7.38M 2026-06
Novavax USD 162.58M 106K 2025-12
Pfizer USD 5.7B 0 2026-06
PTC Therapeutics USD 82.88M 1.41M 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Sarepta Therapeutics USD 105.62M 53K 2026-06
Vertex Pharmaceuticals USD 253.3M 900K 2026-06